Items where authors include "Fisher, M."

Article

Mousavi, M.R. orcid.org/0000-0002-4869-6794, Cavalcanti, A., Fisher, M. orcid.org/0000-0002-0875-3862 et al. (8 more authors) (2023) Trustworthy Autonomous Systems Through Verifiability. Computer, 56 (2). pp. 40-47. ISSN 0018-9162

Mousavi, M.R., Cavalcanti, A., Fisher, M. et al. (8 more authors) (2023) Trustworthy autonomous systems through verifiability. Computer, 56 (2). pp. 40-47. ISSN 0018-9162

Mironov, A., Fisher, M., Narayanan, P. et al. (3 more authors) (2023) Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands. PLOS Biology, 21 (1). e3001583. ISSN 1544-9173

Laskier, V., Guy, H., Fisher, M. et al. (4 more authors) (2019) Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients : a systematic literature review and network meta-analysis. Journal of Medical Economics, 22 (10). pp. 1063-1072. ISSN 1369-6998

Brown, A.W., Holmes, T., Fisher, M. et al. (3 more authors) (2018) Cover feature : Evaluation of sydnone-based analogues of Combretastatin A-4 phosphate (CA4P) as vascular disrupting agents for use in cancer therapy (ChemMedChem 24/2018). ChemMedChem, 13 (24). p. 2600. ISSN 1860-7179

Aitken, J. orcid.org/0000-0003-4204-4020, Veres, S., Shaukat, A. et al. (7 more authors) (2018) Autonomous nuclear waste management. IEEE Intelligent Systems, 33 (6). pp. 47-55. ISSN 1541-1672

Harrity, J.P.A., Brown, A., Holmes, T. et al. (3 more authors) (2018) Evaluation of Sydnone-Based Analogs of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy. ChemMedChem. ISSN 1860-7179

Lath, D.L. orcid.org/0000-0001-5454-9419, Buckle, C.H., Evans, H.R. et al. (4 more authors) (2018) ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo. PLoS One, 13 (6). e0199517. ISSN 1932-6203

Kamali, M., Dennis, L.A., McAree, O. et al. (2 more authors) (2017) Formal verification of autonomous vehicle platooning. Science of Computer Programming, 148. pp. 88-106. ISSN 0167-6423

Byers, R.A., Fisher, M., Brown, N.J. orcid.org/0000-0002-2100-1905 et al. (2 more authors) (2017) Vascular patterning of subcutaneous mouse fibrosarcomas expressing individual VEGF isoforms can be differentiated using angiographic optical coherence tomography. Biomedical Optics Express, 8 (10). pp. 4551-4567. ISSN 2156-7085

Shepherd, J. orcid.org/0000-0001-7661-0698, Fisher, M., Welford, A. et al. (3 more authors) (2017) The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate. Oncotarget, 2017 (8). pp. 95648-95661. ISSN 1949-2553

English, W.R. orcid.org/0000-0003-3024-2441, Lunt, S.J., Fisher, M. et al. (8 more authors) (2017) Differential expression of VEGFA isoforms regulates metastasis and response to anti-VEGFA therapy in sarcoma. Cancer Research, 77 (10). pp. 2633-2646. ISSN 0008-5472

Brown, A.W., Fisher, M., Tozer, G.M. et al. (2 more authors) (2016) Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4. Journal of Medicinal Chemistry, 59 (20). pp. 9473-9488. ISSN 0022-2623

Veres, S.M., Fisher, M., Dennis, L. et al. (2 more authors) (2016) Practical Verification of Decision-Making in Agent-Based Autonomous Systems. Automated Software Engineering, 23 (3). pp. 305-359. ISSN 0928-8910

Dolling, D.I., Desai, M., McOwan, A. et al. (22 more authors) (2016) An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis. Trials, 17 (1). ISSN 1745-6215

McCormack, S., Dunn, D.T., Desai, M. et al. (24 more authors) (2016) Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387 (10013). pp. 53-60. ISSN 0140-6736

Williams, L. J., Mukherjee, D., Fisher, M. et al. (4 more authors) (2014) An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate. British Journal of Pharmacology, 171 (21). pp. 4902-4913. ISSN 0007-1188

Dennis, L.A., Fisher, M., Aitken, J. orcid.org/0000-0003-4204-4020 et al. (4 more authors) (2014) Reconfigurable Autonomy. KI - Künstliche Intelligenz, 28 (3). pp. 199-207. ISSN 0933-1875

Harris, S., Craze, M., Newton, J. et al. (4 more authors) (2012) Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale. PLoS ONE, 7 (5). ARTN e35231. ISSN 1932-6203

Akerman, S., Reyes-Aldasoro, C.C., Fisher, M. et al. (4 more authors) (2011) Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents. Medical Engineering and Physics, 33 (7). pp. 805-809. ISSN 1350-4533

Beck, E.J., Mandalia, S., Lo, G. et al. (16 more authors) (2011) Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006. PLoS One, 6 (5). e20200. ISSN 1932-6203

Dockrell, D. H., Edwards, S., Fisher, M. et al. (2 more authors) (2011) Evolving controversies and challenges in the management of opportunistic infections in HIV-seropositive individuals. The Journal of infection, 63 (3). pp. 177-86. ISSN 1532-2742

Mandalia, S., Mandalia, R., Lo, G. et al. (18 more authors) (2010) Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013. PLoS ONE, 5 (12). e15677. ISSN 1932-6203

Proceedings Paper

Dennis, L.A., Aitken, J.M. orcid.org/0000-0003-4204-4020, Collenette, J. et al. (8 more authors) (2016) Agent-based autonomous systems and abstraction engines: Theory meets practice. In: Alboul , L., Damian, D. and Aitken, J., (eds.) Towards Autonomous Robotic Systems. 17th Annual Conference, Towards Autonomous Robotics, TAROS 2016, 26 June 26 - 1 July, 2016, Sheffield . Lecture Notes in Computer Science (9716). Springer, Cham , pp. 75-86. ISBN 9783319403786